Results 191 to 200 of about 317,712 (289)

Editorial: Exploring novel in vitro models for cystic fibrosis research. [PDF]

Front Pharmacol
Man Y, Mattoscio D, Plebani R.
europepmc   +1 more source

The regional landscape of the human colon culturome in health and cystic fibrosis. [PDF]

Microbiol Spectr
Surve SV, Valls RA, Barrack KE, Gwilt LL, Gardner TB, O'Toole GA.   +5 more
europepmc   +1 more source

Examining the role of freebase nicotine in the harm reduction potential of oral nicotine pouches versus moist snuff: A randomized crossover trial

Addiction, EarlyView.
Abstract Background and aims Oral nicotine pouches (ONPs) contain varying proportions of freebase nicotine (FBN), with higher FBN expected to increase nicotine delivery across the oral mucosa. Because ONPs contain fewer toxicants than moist snuff and may serve as a reduced harm alternative for smokeless tobacco, we compared how the FBN in ONPs affects ...
Brittney Keller‐Hamilton, Hayley Curran, Leanne Atkinson, Sriya Suraapaneni, Alice Hinton, Kirsten Chrzan, Darren Mays, Ahmad El‐Hellani, Clark W. Wilson, Marielle C. Brinkman, Theodore L. Wagener   +10 more
wiley   +1 more source

Increased Vigilance Needed for the Detection of Thrombotic Complications of Central Venous Access in Adolescent Cystic Fibrosis Patients

Frontiers in Pediatrics, 2014
Nandini eKandamany, Basil eElnazir, Peter eGreally   +2 more
doaj   +1 more source

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis

Addiction, EarlyView.
Abstract Background and aims The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and
Sara Weidberg, Clara Iza‐Fernández, Layla Alemán‐Moussa, Andrea Krotter, Alba González‐Roz   +4 more
wiley   +1 more source

Impact of COVID-19 and CFTR Modulators on Cystic Fibrosis: A Real-World Analysis of Care Patterns. [PDF]

Pediatr Pulmonol
Hinton AC, Sears EH, Lopez-Pintado S, Zuckerman JB.   +3 more
europepmc   +1 more source

Steatocystoma Multiplex Suppurativa—A Case Report and Review of Treatments

Australasian Journal of Dermatology, EarlyView.
ABSTRACT We report a case of Steatocystoma Multiplex Suppurativa (SMS), a rare condition that can mimic hidradenitis suppurativa (HS). We also present a review of the surgical and medical therapies, including potential biologic agents.
Justin Tam Vu, Alexis Daniel Lara Rivero
wiley   +1 more source

Diet quality in Brazilian adolescents with cystic fibrosis. [PDF]

J Pediatr (Rio J)
Pascon C, Bellomo-Brandão MA, Ribeiro JD, Lomazi EA.   +3 more
europepmc   +1 more source

Disclosing to parents newborn carrier status identified by routine blood spot screening [PDF]

, 2004
Dezateux, Carol, Kavanagh, Josephine, Lempert, Tami, Oliver, Sandy, Stewart, Ruth   +4 more
core   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source